Asia Pacific Omega 3 Market By Type, By Application, By Source, By Country, Opportunity Analysis and Industry Forecast, 2021-2027

The Asia Pacific Omega 3 Market is expected to witness market growth of 7.1% CAGR during the forecast period (2021-2027).

Omega-3 fatty acids are a good cholesterol that the human body does not produce on its own. Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are two types of omega-3 fatty acids found in fish (DHA). Alpha-linolenic acid is a kind of omega-3 found in plants (ALA). Omega-3 fatty acids assist prevents blood platelets from clumping together, lowering the risk of blood clots. It helps in maintaining the smoothness and absence of damage to the artery lining, which can lead to thick, hard arteries.

This reduces the formation of plaque in the arteries. The consumption of omega-3 can also reduce the formation of triglycerides in the liver lowers triglyceride levels. Triglyceride levels in the blood are linked to an increased risk of heart disease. The inflammatory response of human body is suspected to play a role in atherosclerosis (artery hardening). The generation of chemicals produced during the inflammatory response is slowed by omega-3 fatty acids.

This region offers enormous potential for omega-3 fatty acids, with growth rates likely to outpace the average. The demand for omega-3 acids can be linked to increased consumer awareness of the health benefits as well as rising discretionary earnings, which allow customers to spend on well-being-promoting healthcare items. Dietary supplement demand is rapidly expanding in the region's densely populated countries, such as China and India.

The China market dominated the Asia Pacific Omega 3 Market by Country 2020, and is expected to continue to be a dominant market till 2027; thereby, achieving a market value of $217 million by 2027. The Japan market is poised to grow a CAGR of 6.5% during (2021 - 2027). Additionally, The India market is expected to experience a CAGR of 7.7% during (2021 - 2027).

Based on Type, the market is segmented into Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA), and Alpha-linolenic acid (ALA). Based on Application, the market is segmented into Supplements & Functional Foods, Pharmaceuticals, Infant Formula, Animal Feed & Pet Food and Others. Based on Source, the market is segmented into Marine Source and Plant Source. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Aker BioMarine AS, GC Rieber VivoMega AS (GC Rieber group), Epax Norway AS (Pelagia Holding AS), FMC Corporation, BASF SE, Koninklijke DSM N.V., Lonza Group AG, Orkla ASA (Orkla Health), Croda International PLC, and Omega Protein Corporation (Cooke, Inc.).

Scope of the Study

Market Segments Covered in the Report:

By Type

• Docosahexaenoic acid (DHA)
• Eicosapentaenoic acid (EPA), and
• Alpha-linolenic acid (ALA)

By Application

• Supplements & Functional Foods
• Pharmaceuticals
• Infant Formula
• Animal Feed & Pet Food and
• Others

By Source

• Marine Source and
• Plant Source

By Country

• China
• Japan
• India
• South Korea
• Singapore
• Malaysia
• Rest of Asia Pacific

Key Market Players

List of Companies Profiled in the Report:

• Aker BioMarine AS
• GC Rieber VivoMega AS (GC Rieber group)
• Epax Norway AS (Pelagia Holding AS)
• FMC Corporation
• BASF SE
• Koninklijke DSM N.V.
• Lonza Group AG
• Orkla ASA (Orkla Health)
• Croda International PLC
• Omega Protein Corporation (Cooke, Inc.)

Unique Offerings from the Publisher

• Exhaustive coverage
• The highest number of market tables and figures
• Subscription-based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free